CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
|
Convertible Series F Preferred Stock |
Convertible Series D Preferred Stock |
Convertible Series C Preferred Stock |
Series B Preferred Stock Conversion Liability |
Common Stock |
Additional Paid-In Capital |
Warrant |
Accumulated deficit |
Total |
Balance at Dec. 31, 2016 |
|
|
$ 293,669
|
$ 1,169,663
|
|
|
|
|
|
Balance (Shares) at Dec. 31, 2016 |
|
|
386
|
4,031
|
|
|
|
|
|
Balance at Dec. 31, 2016 |
|
|
|
|
$ 21,563
|
$ 7,163,064
|
$ 837,711
|
$ (10,936,573)
|
$ (2,914,235)
|
Balance (in shares) at Dec. 31, 2016 |
|
|
|
|
21,563,163
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Common stock issued for services |
|
|
|
|
$ 605
|
186,945
|
|
|
187,550
|
Common stock issued for services (in shares) |
|
|
|
|
605,000
|
|
|
|
|
Common stock warrants issued for services |
|
|
|
|
|
|
145,200
|
|
145,200
|
Stock based compensation expense |
|
|
|
|
|
608,676
|
|
|
608,676
|
Issuance of Series D Preferred Stock net of issuance costs of $183,343 |
|
$ 1,016,657
|
|
|
|
|
|
|
|
Issuance of Series D Preferred Stock net of issuance costs of $183,343 (in shares) |
|
1,200
|
|
|
|
|
|
|
|
Issuance of Series F Preferred Stock net of issuance costs of $118,855 and $103,364 put option liability |
$ 1,777,781
|
|
|
|
|
|
|
|
|
Issuance of Series F Preferred Stock net of issuance costs of $118,855 and $103,364 put option liability (in shares) |
2,000
|
|
|
|
|
|
|
|
|
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.25 and $0.15 per share for December 31, 2017 and $0.10 and $0.001 per share for December 31, 2018 |
|
|
|
$ (347,462)
|
$ 5,911
|
350,810
|
|
|
356,721
|
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.80 and $0.40 per share for December 31, 2016 and $0.25 and $0.15 per share for December 31, 2017 (in shares) |
|
|
|
(1,197.45)
|
5,910,666
|
|
|
|
|
Conversion of Series C Preferred Stock to common stock at $0.25 per share for December 31, 2017 |
|
|
$ (293,669)
|
|
$ 1,544
|
292,125
|
|
|
293,669
|
Conversion of Series C Preferred Stock to common stock at $0.40 and $0.25 per share for December 31, 2016 and 2017 respectively (in shares) |
|
|
(386)
|
|
1,544,000
|
|
|
|
|
Conversion of Series D Preferred Stock to common stock at $0.25 and $0.10 per share for December 31, 2016 and December 31, 2017, respectively. |
|
$ (847,210)
|
|
|
$ 4,000
|
843,211
|
|
|
847,211
|
Conversion of Series D Preferred Stock to common stock at $0.25 per share (in shares) |
|
(1,000)
|
|
|
4,000,000
|
|
|
|
|
Beneficial conversion feature upon issuance of Series C Preferred Stock |
|
|
|
|
|
175,000
|
|
|
175,000
|
Deemed dividend from beneficial conversion feature of Series C Preferred Stock |
|
|
|
|
|
(175,000)
|
|
|
(175,000)
|
Beneficial conversion feature upon issuance of Series D Preferred Stock |
|
|
|
|
|
536,000
|
|
|
536,000
|
Deemed dividend from beneficial conversion feature of Series D Preferred Stock |
|
|
|
|
|
(536,000)
|
|
|
(536,000)
|
Beneficial conversion feature upon issuance of Series F Preferred Stock |
|
|
|
|
|
333,000
|
|
|
333,000
|
Deemed dividend from beneficial conversion feature of Series F Preferred Stock |
|
|
|
|
|
(333,000)
|
|
|
(333,000)
|
Net loss for the year |
|
|
|
|
|
|
|
(3,094,298)
|
(3,094,298)
|
Balance at Dec. 31, 2017 |
$ 1,777,781
|
$ 169,447
|
|
$ 822,201
|
$ 33,623
|
9,444,831
|
982,911
|
(14,030,871)
|
(3,569,506)
|
Balance (in shares) at Dec. 31, 2017 |
2,000
|
200
|
|
2,834
|
33,622,829
|
|
|
|
|
Balance at Dec. 31, 2017 |
$ 1,777,781
|
$ 169,447
|
|
$ 822,201
|
|
|
|
|
|
Balance (Shares) at Dec. 31, 2017 |
2,000
|
200
|
|
2,833.55
|
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Stock based compensation expense |
|
|
|
|
$ 2,500
|
227,109
|
|
|
229,609
|
Stock based compensation expense (in shares) |
|
|
|
|
2,500,000
|
|
|
|
|
Issuance of common stock net of issuance costs of $16,900 |
|
|
|
|
$ 32,500
|
(32,500)
|
|
|
|
Issuance of common stock net of issuance costs of $16,900 (in shares) |
|
|
|
|
32,500,000
|
|
|
|
|
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.25 and $0.15 per share for December 31, 2017 and $0.10 and $0.001 per share for December 31, 2018 |
|
|
|
$ (822,201)
|
$ 28,385
|
800,530
|
|
|
828,915
|
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.80 and $0.40 per share for December 31, 2016 and $0.25 and $0.15 per share for December 31, 2017 (in shares) |
|
|
|
(2,834)
|
28,385,000
|
|
|
|
|
Conversion of Series D Preferred Stock to common stock at $0.25 and $0.10 per share for December 31, 2016 and December 31, 2017, respectively. |
|
$ (169,447)
|
|
|
$ 2,000
|
167,447
|
|
|
169,447
|
Conversion of Series D Preferred Stock to common stock at $0.25 per share (in shares) |
|
(200)
|
|
|
2,000,000
|
|
|
|
|
Conversion of Series F Preferred Stock to common stock at $0.10 per share |
$ (1,777,781)
|
|
|
|
$ 20,000
|
1,757,781
|
|
|
1,777,781
|
Conversion of Series F Preferred Stock to common stock at $0.10 per share (in shares) |
(2,000)
|
|
|
|
20,000,000
|
|
|
|
|
Conversion of secured convertible promissory note - related party and accrued interest |
|
|
|
|
$ 9,000
|
1,691,878
|
|
|
1,700,878
|
Conversion of secured convertible promissory note - related party and accrued interest (in shares) |
|
|
|
|
9,000,000
|
|
|
|
|
Series B warrant exercises |
|
|
|
|
$ 4,406
|
1,318,284
|
|
|
1,322,690
|
Series B warrant exercises (in shares) |
|
|
|
|
4,406,250
|
|
|
|
|
Net loss for the year |
|
|
|
|
|
|
|
(8,213,793)
|
(8,213,793)
|
Balance at Mar. 31, 2018 |
|
|
|
|
$ 132,414
|
16,358,271
|
|
(22,244,664)
|
(5,753,979)
|
Balance (in shares) at Mar. 31, 2018 |
|
|
|
|
132,414,079
|
|
|
|
|
Balance at Dec. 31, 2017 |
$ 1,777,781
|
$ 169,447
|
|
$ 822,201
|
|
|
|
|
|
Balance (Shares) at Dec. 31, 2017 |
2,000
|
200
|
|
2,833.55
|
|
|
|
|
|
Balance at Dec. 31, 2017 |
$ 1,777,781
|
$ 169,447
|
|
$ 822,201
|
$ 33,623
|
9,444,831
|
982,911
|
(14,030,871)
|
(3,569,506)
|
Balance (in shares) at Dec. 31, 2017 |
2,000
|
200
|
|
2,834
|
33,622,829
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Net loss for the year |
|
|
|
|
|
|
|
|
(12,972,142)
|
Balance at Sep. 30, 2018 |
|
|
|
|
$ 133,445
|
16,714,448
|
|
(27,003,013)
|
(10,155,120)
|
Balance (in shares) at Sep. 30, 2018 |
|
|
|
|
133,445,080
|
|
|
|
|
Balance at Dec. 31, 2017 |
$ 1,777,781
|
$ 169,447
|
|
$ 822,201
|
|
|
|
|
|
Balance (Shares) at Dec. 31, 2017 |
2,000
|
200
|
|
2,833.55
|
|
|
|
|
|
Balance at Dec. 31, 2017 |
$ 1,777,781
|
$ 169,447
|
|
$ 822,201
|
$ 33,623
|
9,444,831
|
982,911
|
(14,030,871)
|
(3,569,506)
|
Balance (in shares) at Dec. 31, 2017 |
2,000
|
200
|
|
2,834
|
33,622,829
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Stock based compensation expense |
|
|
|
|
$ 3,143
|
671,818
|
|
|
674,961
|
Stock based compensation expense (in shares) |
|
|
|
|
3,143,501
|
|
|
|
|
Issuance of common stock net of issuance costs of $16,900 |
|
|
|
|
$ 32,500
|
(49,400)
|
|
|
(16,900)
|
Issuance of common stock net of issuance costs of $16,900 (in shares) |
|
|
|
|
32,500,000
|
|
|
|
|
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.25 and $0.15 per share for December 31, 2017 and $0.10 and $0.001 per share for December 31, 2018 |
|
|
|
$ (822,201)
|
$ 28,385
|
800,530
|
|
|
828,915
|
Conversion of Series B Preferred Stock and conversion liability into common stock at $0.80 and $0.40 per share for December 31, 2016 and $0.25 and $0.15 per share for December 31, 2017 (in shares) |
|
|
|
(2,833.55)
|
28,385,000
|
|
|
|
|
Conversion of Series D Preferred Stock to common stock at $0.25 and $0.10 per share for December 31, 2016 and December 31, 2017, respectively. |
|
$ (169,447)
|
|
|
$ 2,000
|
167,447
|
|
|
169,447
|
Conversion of Series D Preferred Stock to common stock at $0.25 per share (in shares) |
|
(200)
|
|
|
2,000,000
|
|
|
|
|
Conversion of Series F Preferred Stock to common stock at $0.10 per share |
$ (1,777,781)
|
|
|
|
$ 20,000
|
$ 1,757,781
|
|
|
$ 1,777,781
|
Conversion of Series F Preferred Stock to common stock at $0.10 per share (in shares) |
(2,000)
|
|
|
|
20,000,000
|
|
|
|
|
Conversion of secured convertible promissory note - related party and accrued interest |
|
|
|
|
$ 9,037,667
|
|
|
|
|
Conversion of secured convertible promissory note - related party and accrued interest (in shares) |
|
|
|
|
9,038
|
1,714,522
|
|
|
1,723,560
|
Series B warrant exercises |
|
|
|
|
$ 5,219
|
$ 1,633,347
|
|
|
$ 1,638,566
|
Series B warrant exercises (in shares) |
|
|
|
|
5,218,750
|
|
|
|
|
Warrants issued in connection with convertible multi-draw credit agreement, related party |
|
|
|
|
|
|
315,080
|
|
315,080
|
Beneficial conversion feature in connection with convertible multi-draw credit agreement - related party |
|
|
|
|
|
90,080
|
|
|
90,080
|
Net loss for the year |
|
|
|
|
|
|
|
(19,194,236)
|
(19,194,236)
|
Balance at Dec. 31, 2018 |
|
|
|
|
$ 133,908
|
17,528,947
|
1,297,991
|
(33,225,107)
|
$ (15,562,252)
|
Balance (in shares) at Dec. 31, 2018 |
|
|
|
|
133,907,747
|
|
|
|
|
Balance (Shares) at Dec. 31, 2018 |
0
|
0
|
|
0
|
|
|
|
|
0
|
Balance at Mar. 31, 2018 |
|
|
|
|
$ 132,414
|
16,358,271
|
|
(22,244,664)
|
$ (5,753,979)
|
Balance (in shares) at Mar. 31, 2018 |
|
|
|
|
132,414,079
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Stock based compensation expense |
|
|
|
|
|
100,603
|
|
|
100,603
|
Common stock issuance costs paid of $7,778 |
|
|
|
|
|
(7,778)
|
|
|
(7,778)
|
Series B warrant exercises |
|
|
|
|
$ 288
|
77,587
|
|
|
77,875
|
Series B warrant exercises (in shares) |
|
|
|
|
287,500
|
|
|
|
|
Net loss for the year |
|
|
|
|
|
|
|
(2,662,000)
|
(2,662,000)
|
Balance at Jun. 30, 2018 |
|
|
|
|
$ 132,702
|
16,528,683
|
|
(24,906,664)
|
(8,245,279)
|
Balance (in shares) at Jun. 30, 2018 |
|
|
|
|
132,701,579
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Stock based compensation expense |
|
|
|
|
$ 643
|
153,865
|
|
|
154,508
|
Stock based compensation expense (in shares) |
|
|
|
|
643,501
|
|
|
|
|
Series B warrant exercises |
|
|
|
|
$ 100
|
31,900
|
|
|
32,000
|
Series B warrant exercises (in shares) |
|
|
|
|
100,000
|
|
|
|
|
Net loss for the year |
|
|
|
|
|
|
|
(2,096,349)
|
(2,096,349)
|
Balance at Sep. 30, 2018 |
|
|
|
|
$ 133,445
|
16,714,448
|
|
(27,003,013)
|
(10,155,120)
|
Balance (in shares) at Sep. 30, 2018 |
|
|
|
|
133,445,080
|
|
|
|
|
Balance at Dec. 31, 2018 |
|
|
|
|
$ 133,908
|
17,528,947
|
1,297,991
|
(33,225,107)
|
(15,562,252)
|
Balance (in shares) at Dec. 31, 2018 |
|
|
|
|
133,907,747
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Stock based compensation expense |
|
|
|
|
|
171,493
|
|
|
171,493
|
Warrants issued in connection with convertible multi-draw credit agreement, related party |
|
|
|
|
|
716,110
|
|
|
716,110
|
Beneficial conversion feature in connection with convertible multi-draw credit agreement - related party |
|
|
|
|
|
1,584,850
|
|
|
1,584,850
|
Net loss for the year |
|
|
|
|
|
|
|
(14,774,392)
|
(14,774,392)
|
Balance at Mar. 31, 2019 |
|
|
|
|
$ 133,908
|
20,001,400
|
|
(47,999,499)
|
$ (27,864,191)
|
Balance (in shares) at Mar. 31, 2019 |
|
|
|
|
133,907,747
|
|
|
|
|
Balance (Shares) at Dec. 31, 2018 |
0
|
0
|
|
0
|
|
|
|
|
0
|
Balance at Dec. 31, 2018 |
|
|
|
|
$ 133,908
|
17,528,947
|
$ 1,297,991
|
(33,225,107)
|
$ (15,562,252)
|
Balance (in shares) at Dec. 31, 2018 |
|
|
|
|
133,907,747
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Net loss for the year |
|
|
|
|
|
|
|
|
(3,800,227)
|
Balance at Sep. 30, 2019 |
|
|
|
|
$ 134,095
|
20,488,778
|
|
(37,025,334)
|
$ (16,402,461)
|
Balance (in shares) at Sep. 30, 2019 |
|
|
|
|
134,095,247
|
|
|
|
|
Balance (Shares) at Sep. 30, 2019 |
|
|
|
|
|
|
|
|
0
|
Balance at Mar. 31, 2019 |
|
|
|
|
$ 133,908
|
20,001,400
|
|
(47,999,499)
|
$ (27,864,191)
|
Balance (in shares) at Mar. 31, 2019 |
|
|
|
|
133,907,747
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Stock based compensation expense |
|
|
|
|
|
173,084
|
|
|
173,084
|
Series B warrant exercises |
|
|
|
|
$ 187
|
144,188
|
|
|
144,375
|
Series B warrant exercises (in shares) |
|
|
|
|
187,500
|
|
|
|
|
Net loss for the year |
|
|
|
|
|
|
|
15,905,290
|
15,905,290
|
Balance at Jun. 30, 2019 |
|
|
|
|
$ 134,095
|
20,318,672
|
|
(32,094,209)
|
(11,641,442)
|
Balance (in shares) at Jun. 30, 2019 |
|
|
|
|
134,095,247
|
|
|
|
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
Stock based compensation expense |
|
|
|
|
|
170,106
|
|
|
170,106
|
Net loss for the year |
|
|
|
|
|
|
|
(4,931,125)
|
(4,931,125)
|
Balance at Sep. 30, 2019 |
|
|
|
|
$ 134,095
|
$ 20,488,778
|
|
$ (37,025,334)
|
$ (16,402,461)
|
Balance (in shares) at Sep. 30, 2019 |
|
|
|
|
134,095,247
|
|
|
|
|
Balance (Shares) at Sep. 30, 2019 |
|
|
|
|
|
|
|
|
0
|